Gilead (GILD)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-10 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: Cain Wettan Keeley M CIK: 0002110603 Role: Officer (EVP Gen Counsel, Legal & Comp) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-10 | Code: M (Exercise of derivative) Shares: +6,002 Shares Owned After: 11,362 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [Transaction #2] Security: Common Stock Date: 2026-08-10 | Code: F (Payment of exercise/tax) Shares: -2,908 | Price: $133.06 Total Value: $386,938.48 Shares Owned After: 8,454 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-08-10 | Code: M (Exercise of derivative) Shares: -6,002 Shares Owned After: 13,995 | Ownership: D (Direct) Footnotes: [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. [F2] The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. [F2] The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. --- Footnotes (Complete Index) --- F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2: The restricted stock units have a three-year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. --- Signature --- /s/ /s/ Amy Kim by Power of Attorney for Keeley M. Cain Wettan (2026-08-11)